30.00MMarket Cap
LossP/E TTM
Serina Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Serina Therapeutics Inc is 6.33, ranking 313 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.02, which is -550.78% below the recent high of 4.59 and -559.57% above the recent low of -6.71.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.